The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Exosome Diagnostics and Therapeutics-Global Market Insights and Sales Trends 2025
Synopsis
The global Exosome Diagnostics and Therapeutics market size is expected to reach US$ 825.8 million by 2029, growing at a CAGR of 34.9% from 2023 to 2029. The market is mainly driven by the significant applications of Exosome Diagnostics and Therapeutics in various end use industries. The expanding demands from the Diagnostic and Therapeutic, are propelling Exosome Diagnostics and Therapeutics market. Instrument, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Reagent segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Exosome Diagnostics and Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Exosome Diagnostics and Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Exosome Diagnostics and Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Exosome Diagnostics and Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Exosome Diagnostics and Therapeutics covered in this report include Aethlon Medical(US), Exosome Diagnostics(US), NanoSomix Inc.(US), Thermo Fisher Scientific (US), Malvern Instruments (UK), System Biosciences(US), NX Pharmagen (US), Sistemic Inc(UK) and Capricor Therapeutics (US), etc.
The global Exosome Diagnostics and Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Aethlon Medical(US)
Exosome Diagnostics(US)
NanoSomix Inc.(US)
Thermo Fisher Scientific (US)
Malvern Instruments (UK)
System Biosciences(US)
NX Pharmagen (US)
Sistemic Inc(UK)
Capricor Therapeutics (US)
Exiqon A/S (Denmark)
Global Exosome Diagnostics and Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Exosome Diagnostics and Therapeutics market, Segment by Type:
Instrument
Reagent
Software
Global Exosome Diagnostics and Therapeutics market, by Application
Diagnostic
Therapeutic
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Exosome Diagnostics and Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Exosome Diagnostics and Therapeutics market size is expected to reach US$ 825.8 million by 2029, growing at a CAGR of 34.9% from 2023 to 2029. The market is mainly driven by the significant applications of Exosome Diagnostics and Therapeutics in various end use industries. The expanding demands from the Diagnostic and Therapeutic, are propelling Exosome Diagnostics and Therapeutics market. Instrument, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Reagent segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Exosome Diagnostics and Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Exosome Diagnostics and Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Exosome Diagnostics and Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Exosome Diagnostics and Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Exosome Diagnostics and Therapeutics covered in this report include Aethlon Medical(US), Exosome Diagnostics(US), NanoSomix Inc.(US), Thermo Fisher Scientific (US), Malvern Instruments (UK), System Biosciences(US), NX Pharmagen (US), Sistemic Inc(UK) and Capricor Therapeutics (US), etc.
The global Exosome Diagnostics and Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Aethlon Medical(US)
Exosome Diagnostics(US)
NanoSomix Inc.(US)
Thermo Fisher Scientific (US)
Malvern Instruments (UK)
System Biosciences(US)
NX Pharmagen (US)
Sistemic Inc(UK)
Capricor Therapeutics (US)
Exiqon A/S (Denmark)
Global Exosome Diagnostics and Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Exosome Diagnostics and Therapeutics market, Segment by Type:
Instrument
Reagent
Software
Global Exosome Diagnostics and Therapeutics market, by Application
Diagnostic
Therapeutic
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Exosome Diagnostics and Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Exosome Diagnostics and Therapeutics
1.1 Exosome Diagnostics and Therapeutics Market Overview
1.1.1 Exosome Diagnostics and Therapeutics Product Scope
1.1.2 Exosome Diagnostics and Therapeutics Market Status and Outlook
1.2 Global Exosome Diagnostics and Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Exosome Diagnostics and Therapeutics Market Size by Region (2018-2029)
1.4 Global Exosome Diagnostics and Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Exosome Diagnostics and Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Exosome Diagnostics and Therapeutics Market Size (2018-2029)
1.6.1 North America Exosome Diagnostics and Therapeutics Market Size (2018-2029)
1.6.2 Europe Exosome Diagnostics and Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Exosome Diagnostics and Therapeutics Market Size (2018-2029)
1.6.4 Latin America Exosome Diagnostics and Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size (2018-2029)
2 Exosome Diagnostics and Therapeutics Market by Type
2.1 Introduction
2.1.1 Instrument
2.1.2 Reagent
2.1.3 Software
2.2 Global Exosome Diagnostics and Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Exosome Diagnostics and Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Exosome Diagnostics and Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Exosome Diagnostics and Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Exosome Diagnostics and Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Exosome Diagnostics and Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Exosome Diagnostics and Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Exosome Diagnostics and Therapeutics Revenue Breakdown by Type (2018-2029)
3 Exosome Diagnostics and Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Diagnostic
3.1.2 Therapeutic
3.2 Global Exosome Diagnostics and Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Exosome Diagnostics and Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Exosome Diagnostics and Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Exosome Diagnostics and Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Exosome Diagnostics and Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Exosome Diagnostics and Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Exosome Diagnostics and Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Exosome Diagnostics and Therapeutics Revenue Breakdown by Application (2018-2029)
4 Exosome Diagnostics and Therapeutics Competition Analysis by Players
4.1 Global Exosome Diagnostics and Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Exosome Diagnostics and Therapeutics as of 2022)
4.3 Date of Key Players Enter into Exosome Diagnostics and Therapeutics Market
4.4 Global Top Players Exosome Diagnostics and Therapeutics Headquarters and Area Served
4.5 Key Players Exosome Diagnostics and Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Exosome Diagnostics and Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Aethlon Medical(US)
5.1.1 Aethlon Medical(US) Profile
5.1.2 Aethlon Medical(US) Main Business
5.1.3 Aethlon Medical(US) Exosome Diagnostics and Therapeutics Products, Services and Solutions
5.1.4 Aethlon Medical(US) Exosome Diagnostics and Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Aethlon Medical(US) Recent Developments
5.2 Exosome Diagnostics(US)
5.2.1 Exosome Diagnostics(US) Profile
5.2.2 Exosome Diagnostics(US) Main Business
5.2.3 Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Products, Services and Solutions
5.2.4 Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Exosome Diagnostics(US) Recent Developments
5.3 NanoSomix Inc.(US)
5.3.1 NanoSomix Inc.(US) Profile
5.3.2 NanoSomix Inc.(US) Main Business
5.3.3 NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Products, Services and Solutions
5.3.4 NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Thermo Fisher Scientific (US) Recent Developments
5.4 Thermo Fisher Scientific (US)
5.4.1 Thermo Fisher Scientific (US) Profile
5.4.2 Thermo Fisher Scientific (US) Main Business
5.4.3 Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Products, Services and Solutions
5.4.4 Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Thermo Fisher Scientific (US) Recent Developments
5.5 Malvern Instruments (UK)
5.5.1 Malvern Instruments (UK) Profile
5.5.2 Malvern Instruments (UK) Main Business
5.5.3 Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Products, Services and Solutions
5.5.4 Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Malvern Instruments (UK) Recent Developments
5.6 System Biosciences(US)
5.6.1 System Biosciences(US) Profile
5.6.2 System Biosciences(US) Main Business
5.6.3 System Biosciences(US) Exosome Diagnostics and Therapeutics Products, Services and Solutions
5.6.4 System Biosciences(US) Exosome Diagnostics and Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 System Biosciences(US) Recent Developments
5.7 NX Pharmagen (US)
5.7.1 NX Pharmagen (US) Profile
5.7.2 NX Pharmagen (US) Main Business
5.7.3 NX Pharmagen (US) Exosome Diagnostics and Therapeutics Products, Services and Solutions
5.7.4 NX Pharmagen (US) Exosome Diagnostics and Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 NX Pharmagen (US) Recent Developments
5.8 Sistemic Inc(UK)
5.8.1 Sistemic Inc(UK) Profile
5.8.2 Sistemic Inc(UK) Main Business
5.8.3 Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Products, Services and Solutions
5.8.4 Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Sistemic Inc(UK) Recent Developments
5.9 Capricor Therapeutics (US)
5.9.1 Capricor Therapeutics (US) Profile
5.9.2 Capricor Therapeutics (US) Main Business
5.9.3 Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Products, Services and Solutions
5.9.4 Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 Capricor Therapeutics (US) Recent Developments
5.10 Exiqon A/S (Denmark)
5.10.1 Exiqon A/S (Denmark) Profile
5.10.2 Exiqon A/S (Denmark) Main Business
5.10.3 Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Products, Services and Solutions
5.10.4 Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 Exiqon A/S (Denmark) Recent Developments
6 North America
6.1 North America Exosome Diagnostics and Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Exosome Diagnostics and Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Exosome Diagnostics and Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Exosome Diagnostics and Therapeutics Market Dynamics
11.1 Exosome Diagnostics and Therapeutics Industry Trends
11.2 Exosome Diagnostics and Therapeutics Market Drivers
11.3 Exosome Diagnostics and Therapeutics Market Challenges
11.4 Exosome Diagnostics and Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Industrial Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
